首页 > 市场调查报告书 > 材料

有机化合物

市场调查报告书

商品编码

1684816

邻苯二甲醛市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

Ortho Phthalaldehyde Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年01月14日 | 出版商:

Global Market Insights Inc. | 英文 310 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球邻苯二甲醛市场规模达 59 亿美元，预计 2025 年至 2034 年的复合年增长率为 5.3%。这种化合物以其卓越的消毒和防腐性能而闻名，在各个行业中发挥关键作用。由于其具有很高的杀菌和微生物控制功效，因此被广泛应用于医疗保健、製药、研究实验室和化学领域。由于人们对感染预防意识的增强和卫生标准的严格，对有效消毒解决方案的需求不断增加，市场正在经历强劲增长。

生产和供应链的投资正在增加，而配方技术的进步正在提高产品效率并确保遵守严格的安全和环境法规。人们越来越重视医疗设施和研究环境的卫生，这正在加速其采用，特别是在已开发地区。此外，人们越来越倾向于使用更安全、毒性更小的消毒剂，而不再使用传统替代品，而是选择邻苯二甲醛。业界正积极探索这种多功能化合物的创新应用，进一步加强其市场地位。医疗程序数量的增加、消毒技术的进步以及关键领域对可靠消毒解决方案的日益增长的需求也推动了市场的成长。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	59亿美元
预测值	100亿美元
复合年增长率	5.3%

邻苯二甲醛液态部分在 2024 年创造 34 亿美元，成为多个产业大规模消毒过程的首选。它的稳定性和易用性，加上高效的医疗消毒和较低的毒性，促进了它的广泛应用。业界青睐液体配方，因为它们能够快速消除微生物，同时最大程度地减少对环境的影响。虽然粉末形式占有较小的市场份额，但由于需要干燥配方的利基应用，其需求逐渐增加。这些配方的多功能性确保了它们适用于各种工业应用。

纯度等级>=99%的产品在2024年占据了65.2%的市场份额，体现了其在医疗灭菌和蛋白质检测方面的卓越性能。这些高纯度变异因其精确度和可靠性而受到高度重视，特别是在医院和研究机构等敏感环境中。其极小的残留污染确保了安全性和有效性，使其成为关键应用的首选。同时，纯度为 99% 的产品适用于要求不高的应用，这些应用不需要超高纯度。对更高纯度配方的偏好凸显了在卫生和准确性不可妥协的领域对可靠的灭菌解决方案的需求日益增加。

2024 年，美国邻苯二甲醛市场价值达 17 亿美元，主要得益于其在医疗保健领域的广泛应用，尤其是用于医疗器材的消毒。管理感染控制和外科手术的严格监管标准正在刺激对这种化合物的需求。製造商正专注于先进的配方，以优化功效和安全性，确保符合安全指南。对感染预防的日益重视和高纯度邻苯二甲醛溶液的采用进一步支持了市场扩张。随着消毒技术的不断进步和医疗程序的不断增加，预计未来几年美国市场将持续成长。

产业生态系统分析
- 影响价值链的因素
- 利润率分析
- 中断
- 未来展望
- 製造商
- 经销商
供应商概况
利润率分析
重要新闻及倡议
监管格局
衝击力
- 成长动力
  - 增加医疗保健和医疗设施
  - 不断扩张的製药业
  - 化学工业用量增加
- 产业陷阱与挑战
  - 监管挑战
成长潜力分析
波特的分析
PESTEL 分析

第四章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场规模与预测：依形式，2021-2034 年

主要趋势
液体
粉末

第 6 章：市场规模及预测：依纯度，2021-2034 年

主要趋势
<99％
≥99%

第 7 章：市场规模与预测：按应用，2021-2034 年

主要趋势
医疗消毒
蛋白质检测
光阻
其他的

第 8 章：市场规模与预测：按地区，2021-2034 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 俄罗斯
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
拉丁美洲
- 巴西
- 墨西哥
中东及非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第九章：公司简介

Advanced Sterilization Products
Ataman Kimya
Garonit Pharmaceutical
Lircon
MedPurest
MP Biomedicals
RX Chemicals
Sigma-Aldrich
TCI America
Voda Chemicals
VWR International

简介目录

Product Code: 7117

The Global Ortho Phthalaldehyde Market reached USD 5.9 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2034. This chemical compound, known for its superior disinfectant and antiseptic properties, plays a critical role across various industries. Its widespread use in healthcare, pharmaceuticals, research laboratories, and the chemical sector stems from its high efficacy in sterilization and microbial control. The market is experiencing robust growth due to increasing demand for effective disinfection solutions, driven by heightened awareness of infection prevention and stringent hygiene standards.

Investments in production and supply chains are on the rise, while advancements in formulation techniques are enhancing product efficiency and ensuring compliance with rigorous safety and environmental regulations. The growing emphasis on maintaining hygiene in medical facilities and research environments is accelerating adoption, particularly in developed regions. Additionally, the shift toward safer, less toxic disinfectants is driving a preference for ortho phthalaldehyde over traditional alternatives. Industries are actively exploring innovative applications for this versatile compound, further strengthening its market presence. The market's growth is also supported by the rising number of medical procedures, advancements in disinfection technologies, and the increasing need for reliable sterilization solutions in critical sectors.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$5.9 Billion
Forecast Value	$10 Billion
CAGR	5.3%

The liquid form segment of ortho phthalaldehyde generated USD 3.4 billion in 2024, making it the preferred choice for large-scale disinfection processes across multiple industries. Its stability and ease of use, combined with high effectiveness in medical sterilization and a lower toxicity profile, contribute to its widespread adoption. Industries favor liquid formulations for their ability to deliver quick microbial elimination with minimal environmental impact. While the powder form holds a smaller market share, its demand is gradually increasing due to niche applications that require dry formulations. The versatility of these formulations ensures their relevance across diverse industrial applications.

Products with a purity level of >=99% accounted for 65.2% of the market share in 2024, reflecting their superior performance in medical sterilization and protein detection. These high-purity variants are highly valued for their precision and reliability, particularly in sensitive environments such as hospitals and research institutions. Their minimal residual contamination ensures safety and efficacy, making them the preferred choice for critical applications. Meanwhile, products with a 99% purity level cater to less demanding applications where ultra-high purity is not essential. The preference for higher purity formulations highlights the increasing demand for dependable sterilization solutions in sectors where hygiene and accuracy are non-negotiable.

The US ortho phthalaldehyde market generated USD 1.7 billion in 2024, driven by its extensive use in healthcare, particularly for sterilizing medical instruments. Stringent regulatory standards governing infection control and surgical procedures are fueling demand for this compound. Manufacturers are focusing on advanced formulations to optimize both efficacy and safety, ensuring compliance with safety guidelines. The growing emphasis on infection prevention and the adoption of high-purity ortho phthalaldehyde solutions are further supporting market expansion. With ongoing advancements in disinfection technology and the increasing number of medical procedures, the US market is expected to witness sustained growth in the coming years.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Factor affecting the value chain
- 3.1.2 Profit margin analysis
- 3.1.3 Disruptions
- 3.1.4 Future outlook
- 3.1.5 Manufacturers
- 3.1.6 Distributors
3.2 Supplier landscape
3.3 Profit margin analysis
3.4 Key news & initiatives
3.5 Regulatory landscape
3.6 Impact forces
- 3.6.1 Growth drivers
  - 3.6.1.1 Increased healthcare and medical facilities
  - 3.6.1.2 Expanding pharmaceutical industry
  - 3.6.1.3 Increased chemical industry usage
- 3.6.2 Industry pitfalls & challenges
  - 3.6.2.1 Regulatory challenges
3.7 Growth potential analysis
3.8 Porter’s analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Form, 2021-2034 (USD Billion, Kilo Tons)

5.1 Key trends
5.2 Liquid
5.3 Powder

Chapter 6 Market Size and Forecast, By Purity, 2021-2034 (USD Billion, Kilo Tons)

6.1 Key trends
6.2 <99%
6.3 ≥99%

Chapter 7 Market Size and Forecast, By Application, 2021-2034 (USD Billion, Kilo Tons)

7.1 Key trends
7.2 Medical disinfection
7.3 Protein detection
7.4 Photoresist
7.5 Others

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Million, Kilo Tons)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 UK
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Russia
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE